Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 13Thoracic 2Myeloid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 916Lung Neoplasms 621Small Cell Lung Carcinoma 170Colorectal Neoplasms 133Melanoma 109Breast Neoplasms 107Neoplasms 98Ovarian Neoplasms 94Neoplasm Metastasis 90Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 70Stomach Neoplasms 60Carcinoma, Renal Cell 58Head and Neck Neoplasms 55Esophageal Neoplasms 51Endometrial Neoplasms 51Triple Negative Breast Neoplasms 50Prostatic Neoplasms 47Uterine Cervical Neoplasms 44Colonic Neoplasms 42Urinary Bladder Neoplasms 41Mesothelioma 40Carcinoma, Hepatocellular 38Mesothelioma, Malignant 37Brain Neoplasms 34Sarcoma 29Carcinoma, Transitional Cell 29Adenocarcinoma of Lung 28Lung Diseases 26Disease 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Venous Thromboembolism × Thoracic × 90 days × Clear all
NCT06950697 2026-04-30

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Beijing Chao Yang Hospital

Recruiting
2,400 enrolled
Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT07469488 2026-03-13

AmiCARE

Shanghai Pulmonary Hospital, Shanghai, China

Phase 4 Not yet recruiting
122 enrolled
Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡